Tolentino Carlos Alvarado, Ojeda Diego Venegas
Facultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia, Lima, Perú,
Dirección General de Salud de las Personas, Ministerio de Salud, Lima, Perú
Rev Panam Salud Publica. 2015 Mar;37(3):133-9.
Determine the survival rate of patients diagnosed with stomach cancer in 2009-2010 in Peru.
A retrospective cohort study was conducted of patients diagnosed with stomach cancer registered in the National Epidemiological Surveillance System (SNVE) of the Directorate General of Epidemiology (DGE) and the Register of Vital Statistics (RHV) of the General Office of Statistics and Information (OGEI) for the years 2009-2010.
3 568 patients of the SNVE were included; 51.5% were men and 48.5% were women; the average age was 63.9 years; 60.07% were 60 years old or older. It was found that 33.6% had intestinal type adenocarcinoma, 18.7% had diffuse type carcinoma, and 4.1% had primary gastric lymphoma. The overall survival rate was 29.7 ± 0.8 months and was better for those under 60 years (P = 0.034), for women (P = 0.014) and for intestinal type adenocarcinoma (P< 0.001). There was no difference (P = 0.713) between the survival rate of gastric lymphomas and adenocarcinomas. In order to evaluate mortality, 6 069 patient records from the RHV were included; national mortality was 10.3 per 100 000 population; the regions with the highest mortality were Huánuco, Huancavelica, and Junín.
The general survival rate was 29.7 ± 0.8 months; women, those under 60 years, and patients with intestinal type adenocarcinoma had better survival rates. The highest mortality from stomach cancer is concentrated in the poorest regions of Peru, where it is probable that living conditions facilitate the high communicability of Helicobacter pylori.
确定2009年至2010年在秘鲁被诊断为胃癌的患者的生存率。
对2009年至2010年在流行病学总局(DGE)的国家流行病学监测系统(SNVE)以及统计与信息总局(OGEI)的生命统计登记处(RHV)登记的胃癌患者进行回顾性队列研究。
纳入了SNVE的3568名患者;51.5%为男性,48.5%为女性;平均年龄为63.9岁;60岁及以上者占60.07%。发现33.6%患有肠型腺癌,18.7%患有弥漫型癌,4.1%患有原发性胃淋巴瘤。总生存率为29.7±0.8个月,60岁以下者(P = 0.034)、女性(P = 0.014)以及肠型腺癌患者(P<0.001)的生存率更高。胃淋巴瘤和腺癌的生存率之间无差异(P = 0.713)。为评估死亡率,纳入了RHV的6069份患者记录;全国死亡率为每10万人口10.3例;死亡率最高的地区是瓦努科、万卡韦利卡和胡宁。
总体生存率为29.7±0.8个月;女性、60岁以下者以及肠型腺癌患者的生存率更高。秘鲁胃癌死亡率最高的地区集中在最贫困地区,在这些地区,生活条件可能促使幽门螺杆菌的高传播性。